Application Information

This drug has been submitted to the FDA under the reference 022532/001.

Names and composition

"BEYAZ" is the commercial name of a drug composed of DROSPIRENONE and ETHINYL ESTRADIOL and LEVOMEFOLATE CALCIUM.

Forms

ApplId/ProductId Drug name Active ingredient Form Strenght
022532/001 BEYAZ DROSPIRENONE; ETHINYL ESTRADIOL; LEVOMEFOLATE CALCIUM TABLET/ORAL 3MG,N per A and 0.02MG,N per A and 0.451MG,0.451MG

Similar Active Ingredient

ApplId/ProductId Drug name Active ingredient Form Strenght
022532/001 BEYAZ DROSPIRENONE; ETHINYL ESTRADIOL; LEVOMEFOLATE CALCIUM TABLET/ORAL 3MG,N per A and 0.02MG,N per A and 0.451MG,0.451MG
022574/001 SAFYRAL DROSPIRENONE; ETHINYL ESTRADIOL; LEVOMEFOLATE CALCIUM TABLET/ORAL 3MG,N per A and 0.03MG,N per A and 0.451MG,0.451MG
203593/001 DROSPIRENONE, ETHINYL ESTRADIOL AND LEVOMEFOLATE CALCIUM DROSPIRENONE; ETHINYL ESTRADIOL; LEVOMEFOLATE CALCIUM TABLET/ORAL 3MG,N per A and 0.02MG,N per A and 0.451MG,0.451MG
203594/001 DROSPIRENONE, ETHINYL ESTRADIOL AND LEVOMEFOLATE CALCIUM DROSPIRENONE; ETHINYL ESTRADIOL; LEVOMEFOLATE CALCIUM TABLET/ORAL 3MG,N per A and 0.03MG,N per A and 0.451MG,0.451MG

Ask a doctor

A licensed doctor will try to answer your question for free as quickly as possible. Free of charge during the beta period.

Related

Browse by letter
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

© Medications.li 2015-2017 - All rights reserved